Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma

Published:2021-10 Issue: Volume:518 Page:35-48
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zhao Qitai,Huang Lan^ORCID,Qin Guohui,Qiao Yamin,Ren Feifei,Shen Chunyi,Wang Shumin,Liu Shasha,Lian Jinyao,Wang Dan,Yu Weina,Zhang Yi^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference62 articles.

1. Oesophageal cancer;Smyth;Nat Rev Dis Primers,2017

2. Perioperative management of esophageal cancer;Okines;Nat. Rev. Clin. Oncol.,2010

3. Cancer drug resistance: an evolving paradigm;Holohan;Nat. Rev. Canc.,2013

4. The role of tumour-stromal interactions in modifying drug response: challenges and opportunities;McMillin;Nat. Rev. Drug Discov.,2013

5. A framework for advancing our understanding of cancer-associated fibroblasts;Sahai;Nat. Rev. Canc.,2020

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long noncoding RNAs as potential targets for overcoming chemoresistance in upper gastrointestinal cancers;Biomedicine & Pharmacotherapy;2024-10

2. Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes;Molecular Cancer;2024-09-09

3. Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications;Molecular Cancer;2024-09-07

4. CAFs-derived Exosomal miR-889-3p Might Repress M1 Macrophage Polarization to Boost ESCC Development by Regulating STAT1;Cell Biochemistry and Biophysics;2024-09-05

5. Exosomes in esophageal cancer: Promising nanocarriers in cancer progression, diagnosis, prognosis, and therapy;WIREs Nanomedicine and Nanobiotechnology;2024-09